1. Home
  2. CDNA vs COTY Comparison

CDNA vs COTY Comparison

Compare CDNA & COTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

SELL

Current Price

$64.58

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Logo Coty Inc.

COTY

Coty Inc.

SELL

Current Price

$3.22

Market Cap

2.1B

ML Signal

SELL

Company Overview

Basic Information
Metric
CDNA
COTY
Founded
1998
1904
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
2007
2012

Fundamental Metrics

Financial Performance
Metric
CDNA
COTY
Price
$64.58
$3.22
Analyst Decision
Buy
Hold
Analyst Count
7
17
Target Price
★ $61.67
$2.66
AVG Volume (30 Days)
1.4M
★ 4.8M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.13
N/A
Revenue
$48,324,000.00
★ $5,806,600,000.00
Revenue This Year
$30.36
N/A
Revenue Next Year
$6.23
N/A
P/E Ratio
$31.29
★ N/A
Revenue Growth
★ 18.93
N/A
52 Week Low
$14.03
$1.82
52 Week High
$72.51
$4.34

Technical Indicators

Market Signals
Indicator
CDNA
COTY
Relative Strength Index (RSI) 57.22 75.38
Support Level $61.19 $3.03
Resistance Level $72.51 $3.44
Average True Range (ATR) 3.98 0.11
MACD -0.48 0.06
Stochastic Oscillator 25.72 91.55

Price Performance

Historical Comparison
CDNA
COTY

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About COTY Coty Inc.

Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake.

Share on Social Networks: